{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Collegium Pharmaceutical, Inc."},"Symbol":{"label":"Symbol","value":"COLL"},"Address":{"label":"Address","value":"100 TECHNOLOGY CENTER DRIVE, STOUGHTON, Massachusetts, 02072, United States"},"Phone":{"label":"Phone","value":"+1 781 713-3699"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol."},"CompanyUrl":{"label":"Company Url","value":"https://www.collegiumpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Scott Sudduth","title":"Executive Vice President-Technical Operations"},{"name":"Thomas B. Smith","title":"Chief Medical Officer & Executive Vice President"},{"name":"Vikram Karnani","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}